The World’s First T1D-Focused Scaled Venture Fund

Supporting promising companies through investment and expertise to de-risk programs and propel innovation for type 1 diabetes



A Powerful Platform for Collaboration

We exist to catalyze a world without T1D.

At the T1D Fund, our mission is to accelerate treatments, preventions, and cures for type 1 diabetes (T1D) by catalyzing investment in T1D-focused companies. Our primary goal is to support these innovative companies by being a critical thought partner. We leverage our intellectual capital and expert network to offer comprehensive support to our portfolio companies, steering them through regulatory, clinical, and commercial milestones with a combination of scientific expertise, deep industry experience, as well as the network and resources of Breakthrough T1D.

0

0

0

0

0

The T1D Fund & Breakthrough T1D (Formerly JDRF)

The T1D Fund is a wholly owned, not-for-profit subsidiary and the venture investment entity of Breakthrough T1D, the leading global organization focused on finding a cure for T1D and supporting those affected by it. The Fund is governed by a distinct board and works in partnership with an independent Investment Committee. Led by a deeply experienced team of healthcare and investment professionals, the Fund leverages Breakthrough T1D's extensive research, clinical, regulatory, and medical expertise and network to identify and support companies with the potential to accelerate the development of treatments and cures for T1D.

Through this unique relationship, the T1D Fund brings deep knowledge of the T1D ecosystem and industry dynamics to the broader life sciences investment community while helping portfolio companies advance and expedite the development of their clinical pipelines.

Together, the T1D Fund and Breakthrough T1D are united in their commitment to supporting innovation that accelerates progress toward cures.

Learn more about the T1D Fund’s governance and structure